Results from a large multinational clinical trial (guardian™3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: Safety, efficacy and pharmacokinetics

R. Kulkarni, F. A. Karim, S. Glamocanin, D. Janic, V. Vdovin, M. Ozelo, L. Rageliene, E. Carboni, P. Laguna, G. Dobaczewski, S. Seremetis, A. Lindblom, E. Santagostino

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Results from a large multinational clinical trial (guardian™3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: Safety, efficacy and pharmacokinetics'. Together they form a unique fingerprint.

Medicine & Life Sciences